Giladi E - Search Results

1

Anti-inflammatory Effects of the Octapeptide NAP in Human Microbiota-Associated Mice Suffering from Subacute Ileitis.

Escher U, Giladi E, Dunay IR, Bereswill S, Gozes I, Heimesaat MM. Escher U, et al. Among authors: giladi e. Eur J Microbiol Immunol (Bp). 2018 May 23;8(2):34-40. doi: 10.1556/1886.2018.00006. eCollection 2018 Jun 25. Eur J Microbiol Immunol (Bp). 2018. PMID: 29997909 Free PMC article.

2

NAP accelerates the performance of normal rats in the water maze.

Gozes I, Alcalay R, Giladi E, Pinhasov A, Furman S, Brenneman DE. Gozes I, et al. Among authors: giladi e. J Mol Neurosci. 2002 Aug-Oct;19(1-2):167-70. doi: 10.1007/s12031-002-0028-0. J Mol Neurosci. 2002. PMID: 12212775

3

Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults.

Zaltzman R, Beni SM, Giladi E, Pinhasov A, Steingart RA, Romano J, Shohami E, Gozes I. Zaltzman R, et al. Among authors: giladi e. Neuroreport. 2003 Mar 3;14(3):481-4. doi: 10.1097/00001756-200303030-00037. Neuroreport. 2003. PMID: 12634508

4

The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide.

Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart RA, Giladi E, Gozes I. Ashur-Fabian O, et al. Among authors: giladi e. Peptides. 2003 Sep;24(9):1413-23. doi: 10.1016/j.peptides.2003.08.005. Peptides. 2003. PMID: 14706557

5

Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze.

Alcalay RN, Giladi E, Pick CG, Gozes I. Alcalay RN, et al. Among authors: giladi e. Neurosci Lett. 2004 May 6;361(1-3):128-31. doi: 10.1016/j.neulet.2003.12.005. Neurosci Lett. 2004. PMID: 15135910

6

NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.

Shiryaev N, Jouroukhin Y, Giladi E, Polyzoidou E, Grigoriadis NC, Rosenmann H, Gozes I. Shiryaev N, et al. Among authors: giladi e. Neurobiol Dis. 2009 May;34(2):381-8. doi: 10.1016/j.nbd.2009.02.011. Epub 2009 Mar 2. Neurobiol Dis. 2009. PMID: 19264130

7

The octapetide NAP alleviates intestinal and extra-intestinal anti-inflammatory sequelae of acute experimental colitis.

Heimesaat MM, Giladi E, Kühl AA, Bereswill S, Gozes I. Heimesaat MM, et al. Among authors: giladi e. Peptides. 2018 Mar;101:1-9. doi: 10.1016/j.peptides.2017.12.023. Epub 2017 Dec 27. Peptides. 2018. PMID: 29288684 Free article.

8

Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond.

Kapitansky O, Giladi E, Jaljuli I, Bereswill S, Heimesaat MM, Gozes I. Kapitansky O, et al. Among authors: giladi e. J Neural Transm (Vienna). 2020 Feb;127(2):251-263. doi: 10.1007/s00702-020-02155-5. Epub 2020 Feb 18. J Neural Transm (Vienna). 2020. PMID: 32072336 Free PMC article.

9

Immune-modulatory Properties of the Octapeptide NAP in Campylobacter jejuni Infected Mice Suffering from Acute Enterocolitis.

Heimesaat MM, Mousavi S, Kløve S, Genger C, Weschka D, Giladi E, Bereswill S, Gozes I. Heimesaat MM, et al. Among authors: giladi e. Microorganisms. 2020 May 26;8(6):802. doi: 10.3390/microorganisms8060802. Microorganisms. 2020. PMID: 32466564 Free PMC article.

10

Age and Sex-Dependent ADNP Regulation of Muscle Gene Expression Is Correlated with Motor Behavior: Possible Feedback Mechanism with PACAP.

Kapitansky O, Sragovich S, Jaljuli I, Hadar A, Giladi E, Gozes I. Kapitansky O, et al. Among authors: giladi e. Int J Mol Sci. 2020 Sep 14;21(18):6715. doi: 10.3390/ijms21186715. Int J Mol Sci. 2020. PMID: 32937737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results